CRCRX Mutual Fund

NAV$11.07

Fund Essentials - as of Apr 30, 2026

Net Assets
$2M
Expense Ratio
1.93%
Dividend Yield (Current)
2.14%
Holdings
44
Inception Date
Jan 17, 2003
Fund Family
New York Life Investment Management LLC
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly
SEC 30-Day Yield
PRO

Performance

YTD+15.02%
1 Year+14.02%
3 Year+7.38%
5 Year+2.10%
10 Year+3.72%

Asset Allocation

Stocks: 98.84%
Cash: 0.32%
Other: 0.84%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
WELLWelltower Inc12.43%
EQIXEquinix Inc. Real Estate Investment Trust10.06%
AMTAmerican Tower Corporation7.76%
PLDPrologis Inc6.65%
SPGSimon Property Group Inc5.38%
Top 10 Concentration: 58.01%Report Date: Apr 30, 2026
Download all 44 holdings for CRCRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.14%
Frequency
Quarterly
Latest Distribution
$0.20
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how CRCRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

CRCRX Mutual Fund Overview

CRCRX Mutual Fund (NYLI CBRE Real Estate Fund Class C) is managed by New York Life Investment Management LLC with $2.3M in net assets. CRCRX expense ratio is 1.93%, holding 44 positions across sectors including Real Estate, Unknown, Industrials. Inception date: 2003-01-17.

CRCRX performance shows a YTD return of 15.02%. The 1-year return is 14.02% and the 5-year return is 2.10%. CRCRX dividend yield stands at 2.14%, paid quarterly.

CRCRX top holdings include Welltower Inc (12.4%), Equinix Inc. Real Estate Investment Trust (10.1%), American Tower Corporation (7.8%), Prologis Inc (6.7%), Simon Property Group Inc (5.4%). View all CRCRX holdings, sector breakdown, or dividend history.

CRCRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. CRCRX alternatives are available via the screener, along with tax-loss harvesting opportunities.